Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$77,749,239
-$2,441,941 QoQ
Shares Held
1,483,198
+2.1% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#31
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRANDES INVESTMENT PARTNERS, LP holds $1,062,449,068 across 8 Drug Manufacturers - General names. GSK ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GRFS |
Grifols SA
|
37,816,285 | $267,739,296 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,910,947 | $245,556,688 | |
| 3 | PFE |
Pfizer Inc
|
7,634,806 | $183,846,126 | |
| 4 | SNY |
Sanofi
|
4,136,417 | $176,459,547 | |
| 5 | GSK |
GSK plc
This page
|
1,483,198 | $77,749,239 | |
| 6 | JNJ |
Johnson & Johnson
|
276,623 | $70,253,942 | |
| 7 | NVS |
Novartis AG
|
197,593 | $30,966,774 | |
| 8 | OGN |
Organon & Co.
|
729,502 | $9,877,456 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,749,239 | 1,483,198 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $80,191,180 | 1,453,002 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $84,573,207 | 1,724,576 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $80,623,051 | 1,868,004 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $67,869,503 | 1,767,435 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $65,078,860 | 1,679,888 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $46,036,087 | 1,361,209 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $44,062,793 | 1,077,857 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $44,102,211 | 1,145,512 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $46,488,785 | 1,084,413 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $39,481,240 | 1,065,333 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $24,781,768 | 683,635 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $23,183,534 | 650,492 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $22,836,773 | 641,843 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $751,573 | 21,388 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $17,474,915 | 593,779 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,297,101 | 709,630 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $34,195,878 | 800,397 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $37,409,371 | 864,891 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $32,622,803 | 870,490 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $34,967,715 | 895,335 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $30,288,806 | 865,277 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $27,400,768 | 759,162 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $26,868,714 | 727,808 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $37,565,054 | 938,966 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $46,406,426 | 1,248,743 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||